Balance Sheet
Cash Flow Statement
Net Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innate Pharma (IPHA) Change in Intangibles (2019 - 2023)

Historic Change in Intangibles for Innate Pharma (IPHA) over the last 5 years, with Q4 2023 value amounting to -$2.2 million.

  • Innate Pharma's Change in Intangibles fell 25931.43% to -$2.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$3.2 million, marking a year-over-year increase of 7587.32%. This contributed to the annual value of -$2.2 million for FY2023, which is 25931.43% down from last year.
  • As of Q4 2023, Innate Pharma's Change in Intangibles stood at -$2.2 million, which was down 25931.43% from -$598885.2 recorded in Q4 2022.
  • Innate Pharma's 5-year Change in Intangibles high stood at -$39741.0 for Q2 2021, and its period low was -$72.1 million during Q2 2019.
  • For the 5-year period, Innate Pharma's Change in Intangibles averaged around -$21.1 million, with its median value being -$6.2 million (2020).
  • Its Change in Intangibles has fluctuated over the past 5 years, first soared by 9961.23% in 2021, then plummeted by 25931.43% in 2023.
  • Innate Pharma's Change in Intangibles (Quarter) stood at -$71.0 million in 2019, then skyrocketed by 82.57% to -$12.4 million in 2020, then skyrocketed by 96.29% to -$458732.4 in 2021, then tumbled by 30.55% to -$598885.2 in 2022, then tumbled by 259.31% to -$2.2 million in 2023.
  • Its last three reported values are -$2.2 million in Q4 2023, -$598885.2 for Q4 2022, and -$458732.4 during Q4 2021.